DDX53 and neoplasm: To exam the anticancer outcome of Zn-Fu MNs, as shown in the experimental procedure (Figure S12), CT26-tumor-bearing Balb/c mice received the subcutaneously immunized treatment with injection: PBS, Fu, Zn2+, Zn-Fu MNs on day 0, 2, 4.